Novo Nordisk's new weight-loss pill meets main goal in late-stage diabetes study
April 23 (Reuters) - Novo Nordisk's oral GLP-1 drug met the main goal of a late-stage study in child...
23rd April, 2026
April 23 (Reuters) - Novo Nordisk's oral GLP-1 drug met the main goal of a late-stage study in child...
23rd April, 2026

April 23 (Reuters) - Hikma Pharmaceuticals reiterated its 2026 guidance on Thursday, adding that whi...
23rd April, 2026
LONDON, April 23 (Reuters) - French drugmaker Sanofi on Thursday reported first-quarter profit and r...
23rd April, 2026
By Maggie Fick BARCELONA, April 22 (Reuters) - European Union authorities need a broader remit to se...
22nd April, 2026
By Andrew Silver SHANGHAI, April 22 (Reuters) - Pfizer’s GLP-1 weight management treatment Xianweiyi...
22nd April, 2026
April 21 (Reuters) - Moderna said on Tuesday it had started a late-stage study of its experimental b...
21st April, 2026
FRANKFURT, April 21 (Reuters) - AstraZeneca's CEO told daily Handelsblatt on Tuesday that Germany ri...
21st April, 2026
LONDON, April 20 (Reuters) - A British-based pharmacist wanted in India for allegedly poisoning his...
20th April, 2026
By Maggie Fick LONDON, April 14 (Reuters) - Danish drugmaker Novo Nordisk, which has fallen behind E...
14th April, 2026
April 10 (Reuters) - Swiss contract drugmaker PolyPeptide Group AG is attracting potential takeover...
13th April, 2026
By Bhanvi Satija LONDON, April 12 (Reuters) - British drugmaker GSK's experimental targeted cancer d...
12th April, 2026
By Michael Erman NEW YORK, April 7 (Reuters) - A top Bayer AG executive said on Tuesday the German d...
7th April, 2026